Chemed Corporation $CHE Shares Acquired by Y Intercept Hong Kong Ltd

Posted by Brian Himes on Jul 8th, 2026

Y Intercept Hong Kong Ltd lifted its stake in shares of Chemed Corporation (NYSE:CHE – Free Report) by 28.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,966 shares of the company’s stock after purchasing an additional 1,540 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Chemed were worth $2,631,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Monetary Solutions Ltd purchased a new position in Chemed during the 4th quarter worth $25,000. Los Angeles Capital Management LLC purchased a new stake in shares of Chemed in the fourth quarter valued at about $26,000. BOK Financial Private Wealth Inc. acquired a new position in shares of Chemed during the fourth quarter worth about $27,000. Global Retirement Partners LLC raised its holdings in Chemed by 200.0% during the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after purchasing an additional 58 shares in the last quarter. Finally, Rothschild Investment LLC raised its holdings in Chemed by 800.0% during the fourth quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock worth $46,000 after purchasing an additional 96 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the transaction, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is owned by company insiders.

Chemed Trading Up 1.0%

Shares of CHE stock opened at $485.48 on Wednesday. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. The stock has a market cap of $6.44 billion, a P/E ratio of 26.46, a P/E/G ratio of 1.77 and a beta of 0.52. The business has a fifty day simple moving average of $439.37 and a 200-day simple moving average of $427.55. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $492.30.

Chemed (NYSE:CHE – Get Free Report) last announced its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company had revenue of $657.51 million for the quarter, compared to the consensus estimate of $659.22 million. During the same quarter in the prior year, the firm earned $5.63 earnings per share. The company’s revenue for the quarter was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, analysts forecast that Chemed Corporation will post 22.67 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were paid a $0.60 dividend. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is presently 13.08%.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the company. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Royal Bank Of Canada raised their price target on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a report on Monday, April 27th. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research note on Monday, June 8th. Finally, Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $501.50.

Get Our Latest Stock Analysis on CHE

About Chemed

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.